MODERATOR(S)
Salma Jabbour, MD, FASTRO - Rutgers Cancer Institute
session DESCRIPTION
External beam radiation therapy for rectal, thoracic, and H&N cancers is the standard of care and provides cure. Because of the potential risks of delivering high-dose radiotherapy to the sensitive organs of the pelvis, thorax, and H&N, in-depth knowledge of the anatomy and normal tissue dose constraints are essential. Optimal radiation design and treatment may be needed given advances in higher doses to the primary tumor and changes in patterns of treatment planning. Given rapid incorporation of technological advances in radiation therapy, more conformal radiotherapy design protects organs at risk. Gaining knowledge in contouring both normal tissues and clinical target volumes will help improve outcomes for patients who require these therapies.
learning objectives
- Design appropriate Gross Tumor Volumes and Clinical Target Volumes for rectal, thoracic, and H&N cancers based on tumor characteristics using contouring software to practice this knowledge.
- Select appropriate doses for target volumes based on the available data.
- Identify organs and risk and appropriate dose ranges for rectal, thoracic, and H&N cancers.
Presentations
-
10:45am - 11:10am ETSpeaker: Manisha Palta, MD - Duke Cancer Institute, Durham
-
11:10am - 11:35am ETSpeaker: Salma Jabbour, MD, FASTRO - Rutgers Cancer Institute, New Brunswick
-
11:35am - 12:00pm ETSpeaker: Thomas Galloway, MD, FASTRO - Fox Chase Cancer Center, Philadelphia